Center to Offer First MRI-guided Radiation Therapy in Illinois
MAYWOOD, IL – Loyola Medicine and Palos Health today announced plans to establish a joint venture to offer radiation oncology services at Palos Health South Campus in Orland Park.
The joint venture, named South Campus Partners, LLC, will strengthen the exclusive academic partner affiliation between Loyola and Palos and enhance delivery of world-class ambulatory care in the southwest suburbs.
“Loyola is excited to expand our existing oncology program and services to include state-of-the-art Radiation Oncology services on Palos’ south campus,” said Daniel J. Post, regional executive vice president for strategy and business development, Trinity Health Illinois. “We are committed to partnering with Palos to offer multi-disciplinary, collaborative oncology care close to home.”
Trinity Health Illinois is a regional system of Trinity Health – one of the nation’s largest healthcare systems with 93 hospitals in 22 states – that includes Loyola University Health System (Loyola University Medical Center, Gottlieb Memorial Hospital and a large ambulatory network) and Mercy Hospital & Medical Center.
Palos Health is a fully integrated, community-based healthcare system consisting of Palos Hospital, Palos Medical Group, Palos South Campus in Orland Park, Palos Home Care and Hospice and Chicago Health Colleagues, a clinically integrated physician network.
South Campus Partners, LLC, will be governed by a board with equal representation from Loyola and Palos.
“With this joint venture, Palos patients will have even greater access to Loyola’s academic expertise right in our neighborhood,” said Terrence Moisan, MD, president & CEO of Palos.
Radiation oncology services at the Loyola Center for Cancer Care & Research at Palos Health South Campus, 15300 West Avenue in Orland Park, will open in the summer of 2018 and be located in 13,000-square-feet of newly constructed space.
Raymond B. Wynn, MD, FACR, an internationally known radiation oncologist at Loyola, has been selected as the medical director of radiation oncology for this new facility.
The unit will feature the first radiation therapy system in Illinois that’s guided in real time by MRI imaging. During radiation therapy, tissues move when a patient breathes. The MRI-guided system, called MRIdian®, can simultaneously image and treat cancer patients, precisely targeting moving tumors while avoiding surrounding tissue.
“The ability to see, adapt and treat with MRI-guided radiotherapy will benefit our patients in multiple ways,” said William Small, Jr., MD, FACRO, FACR, FASTRO, chair of Loyola’s department of radiation oncology.
Nearly two years ago, Loyola and Palos entered into a clinical affiliation agreement. Since then, affiliation developments have included:
- A 24/7 telestroke program that brings the expertise of Loyola stroke specialists to the patient’s bedside at Palos via a telemedicine robot.
- The Loyola Center for Cancer Care & Research at Palos Community Hospital, which provides access to Loyola oncology experts, experimental new drugs and clinical trials, as well as an on-site chemotherapy infusion center.
- Specialty care from Loyola’s medical and surgical oncologists and orthopaedic and neurosurgery surgical services.
- Streamlined trauma transfers and subspecialty referrals from Palos to Loyola.
- Educational programming for Palos physicians by teleconferenced grand rounds and continuing medical education courses.
- Palos and Loyola now have compatible electronic medical records systems making it easier for clinicians to access medical records across both systems.
As with previous steps in this innovative partnership, Palos will remain independent. Each organization will maintain its own culture, mission and commitment to the community, and financial and organizational structures will remain separate.